Funder
Emil Aaltosen Säätiö
Academy of Finland
Sigrid Juséliuksen Säätiö
Jane ja Aatos Erkon Säätiö
Biocenter Finland
Magnus Ehrnroothin Säätiö
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Continuous Flow Synthesis of the PARP-1/2 Inhibitor HYDAMTIQ: Synthetic Strategy, Optimization, and Green Metrics Evaluation;Organic Process Research & Development;2023-11-14
2. [1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes;J MED CHEM;2023
3. [1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes;Journal of Medicinal Chemistry;2023-01-04
4. [1,2,4]Triazolo[3,4-b]benzothiazole scaffold as versatile nicotinamide mimic allowing nanomolar inhibition of different PARP enzymes;2022-08-30
5. Identification of PARP12 Inhibitors By Virtual Screening and Molecular Dynamics Simulations;Frontiers in Pharmacology;2022-08-09